XBiotech (XBIT) Competitors $2.89 -0.07 (-2.36%) As of 03:37 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock XBIT vs. SANA, SNDL, ERAS, ORKA, ORIC, CKPT, TECX, RGNX, OLMA, and BNTCShould you be buying XBiotech stock or one of its competitors? The main competitors of XBiotech include Sana Biotechnology (SANA), SNDL (SNDL), Erasca (ERAS), Oruka Therapeutics (ORKA), ORIC Pharmaceuticals (ORIC), Checkpoint Therapeutics (CKPT), Tectonic Therapeutic (TECX), REGENXBIO (RGNX), Olema Pharmaceuticals (OLMA), and Benitec Biopharma (BNTC). These companies are all part of the "pharmaceutical products" industry. XBiotech vs. Sana Biotechnology SNDL Erasca Oruka Therapeutics ORIC Pharmaceuticals Checkpoint Therapeutics Tectonic Therapeutic REGENXBIO Olema Pharmaceuticals Benitec Biopharma Sana Biotechnology (NASDAQ:SANA) and XBiotech (NASDAQ:XBIT) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, dividends, media sentiment, institutional ownership, earnings, community ranking, valuation and profitability. Which has stronger earnings & valuation, SANA or XBIT? XBiotech has higher revenue and earnings than Sana Biotechnology. XBiotech is trading at a lower price-to-earnings ratio than Sana Biotechnology, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSana BiotechnologyN/AN/A-$283.26M-$1.16-1.53XBiotech$4.01M21.97-$24.56M-$1.26-2.29 Is SANA or XBIT more profitable? XBiotech's return on equity of -15.99% beat Sana Biotechnology's return on equity.Company Net Margins Return on Equity Return on Assets Sana BiotechnologyN/A -84.22% -44.97% XBiotech N/A -15.99%-14.85% Do insiders and institutionals hold more shares of SANA or XBIT? 88.2% of Sana Biotechnology shares are owned by institutional investors. Comparatively, 55.7% of XBiotech shares are owned by institutional investors. 31.1% of Sana Biotechnology shares are owned by company insiders. Comparatively, 33.1% of XBiotech shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Which has more volatility & risk, SANA or XBIT? Sana Biotechnology has a beta of 1.78, indicating that its stock price is 78% more volatile than the S&P 500. Comparatively, XBiotech has a beta of 1.28, indicating that its stock price is 28% more volatile than the S&P 500. Does the media prefer SANA or XBIT? In the previous week, Sana Biotechnology had 21 more articles in the media than XBiotech. MarketBeat recorded 22 mentions for Sana Biotechnology and 1 mentions for XBiotech. XBiotech's average media sentiment score of 0.75 beat Sana Biotechnology's score of 0.03 indicating that XBiotech is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Sana Biotechnology 1 Very Positive mention(s) 3 Positive mention(s) 15 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral XBiotech 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Does the MarketBeat Community believe in SANA or XBIT? XBiotech received 293 more outperform votes than Sana Biotechnology when rated by MarketBeat users. Likewise, 69.98% of users gave XBiotech an outperform vote while only 64.86% of users gave Sana Biotechnology an outperform vote. CompanyUnderperformOutperformSana BiotechnologyOutperform Votes2464.86% Underperform Votes1335.14% XBiotechOutperform Votes31769.98% Underperform Votes13630.02% Do analysts recommend SANA or XBIT? Sana Biotechnology presently has a consensus target price of $10.80, suggesting a potential upside of 508.45%. Given Sana Biotechnology's stronger consensus rating and higher probable upside, analysts plainly believe Sana Biotechnology is more favorable than XBiotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sana Biotechnology 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86XBiotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummarySana Biotechnology and XBiotech tied by winning 8 of the 16 factors compared between the two stocks. Get XBiotech News Delivered to You Automatically Sign up to receive the latest news and ratings for XBIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart XBIT vs. The Competition Export to ExcelMetricXBiotechPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$88.11M$6.65B$5.43B$7.80BDividend YieldN/A3.20%5.44%4.31%P/E Ratio-2.687.1722.2418.35Price / Sales21.97238.67389.36100.72Price / CashN/A65.6738.2034.62Price / Book0.406.266.654.17Net Income-$24.56M$142.48M$3.21B$247.71M7 Day Performance-1.70%7.74%5.49%6.17%1 Month Performance-12.42%-6.18%-4.63%-3.37%1 Year Performance-64.80%-0.87%17.67%5.25% XBiotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)XBITXBiotech0.7462 of 5 stars$2.89-2.4%N/A-63.3%$88.11M$4.01M-2.68100News CoveragePositive NewsSANASana Biotechnology2.2513 of 5 stars$1.59-3.6%$10.80+579.2%-79.4%$357.79MN/A-1.14380Analyst ForecastSNDLSNDL2.7882 of 5 stars$1.36-2.9%$3.63+166.5%-26.0%$357.38M$920.45M-4.39580Upcoming EarningsERASErasca3.1416 of 5 stars$1.24+6.9%$4.83+289.8%-25.5%$351.25MN/A-1.49120News CoveragePositive NewsGap DownORKAOruka Therapeutics2.7352 of 5 stars$9.30+0.9%$39.86+328.6%N/A$348.20MN/A-1.49N/AORICORIC Pharmaceuticals3.5509 of 5 stars$4.87+2.1%$18.86+287.2%-35.8%$345.90MN/A-2.6880News CoverageGap DownCKPTCheckpoint Therapeutics1.5573 of 5 stars$4.04flat$4.33+7.3%+184.0%$338.41M$41,000.00-2.2010TECXTectonic Therapeutic2.7442 of 5 stars$17.92+5.3%$72.40+304.0%N/A$334.44MN/A-3.04120Gap UpRGNXREGENXBIO4.5879 of 5 stars$6.67+12.3%$31.63+374.1%-42.6%$334.28M$83.33M-1.33370Positive NewsOLMAOlema Pharmaceuticals2.7026 of 5 stars$4.75+7.5%$27.67+482.5%-49.8%$324.58MN/A-2.1770News CoveragePositive NewsBNTCBenitec Biopharma2.4798 of 5 stars$13.80+0.4%$24.71+79.1%+106.8%$323.62M$80,000.00-9.1420Positive News Related Companies and Tools Related Companies SANA Competitors SNDL Competitors ERAS Competitors ORKA Competitors ORIC Competitors CKPT Competitors TECX Competitors RGNX Competitors OLMA Competitors BNTC Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:XBIT) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XBiotech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share XBiotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy XBIT Stock Free XBIT Stock Alerts